Filing Details

Accession Number:
0001209191-14-059877
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2014-09-26 11:33:09
Reporting Period:
2014-09-23
Filing Date:
2014-09-26
Accepted Time:
2014-09-26 11:33:09
Original Submission Date:
2014-09-25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1412067 Oncothyreon Inc. ONTY Services-Commercial Physical & Biological Research (8731) 260868560
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1413350 Jay Venkatesan C/O Oncothyreon Inc.
2601 Fourth Ave., Suite 500
Seattle WA 98121
Evp And General Manager No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-09-23 250,000 $2.00 250,000 No 4 P Indirect By Ayer Special Situations Fund I, LP
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Ayer Special Situations Fund I, LP
Footnotes
  1. This amended Form 4 is being filed only to reflect that the shares in this line were "purchased" using code "P" instead of being "acquired" using code "A", which was an inadvertent error. No other changes are reflected in this amended Form 4.
  2. The securities are held by Ayer Special Situations Fund I, LP ("ASSF"), the investment advisor of which is Ayer Capital Management, LP ("ACM LP"). The reporting person is a managing member of ACM LP, and may be deemed to share voting and investment power over the securities held by ASSF. The reporting person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.